加多皮克伦醇的发现:理性药物设计的一个例子?
1From the Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Equipe Chimie Moléculaire, Conservatoire National des Arts et Métiers, Paris, France.
Investigative radiology
|March 11, 2025
概括
加多皮克伦醇是一种新的MRI对比剂,其设计采用基于物质的药物设计原则. 其发展发展以优先考虑患者安全,导致较低的批准剂量减少加多暴露.
科学领域:
- 药用化学 医学化学
- 放射性药物开发 放射性药物开发
- 诊断成像 诊断成像 诊断成像
背景情况:
- 加多皮克伦醇最初被开发为一种高放松度的MRI对比剂.
- 设计考虑包括物理化学性质,药理动力学,毒性和复杂稳定性.
- 最初的原型由于安全问题而进行了修改,例如质性全身纤维化.
研究的目的:
- 详细介绍了gadopiclenol的理性,多参数分子设计.
- 为了解释gadopiclenol的药物标特征和医疗定位的演变.
- 在开发诊断剂时强调基于属性的药物设计的应用.
主要方法:
- 基于具有特定结构特征的加多复合体的合理分子设计 (宏环,非离子,硬质约束,水友臂).
- 通过异构化过程对初始原型 (P03277V1) 进行修改,以提高稳定性和降低成本.
- 对物理化学性质,稳定性和安全性质的评估.
主要成果:
- 加多皮克伦醇是用宏环,非离子结构,硬质约束和水友的悬挂臂创建的,以提高安全性和有效性.
- 一个异构化过程导致了具有出色的动力稳定性的gadopiclenol.
- 该剂的医疗定位转向较低剂量 (0.05 mmol/kg),以尽量减少加多暴露和相关风险.
结论:
- 加多皮克伦醇的开发是基于性质的药物设计的典范,其复杂性与治疗剂设计相美.
- 加多皮克伦醇的演变表明了临床开发期间医疗定位的动态性质.
- 目前使用低剂量优先考虑患者的安全,未来可能使用更高剂量来增强诊断.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.6K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.4K
相关概念视频
01:28Structure-Activity Relationships and Drug Design
474
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
01:26Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
01:30Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:26Drug Administration and Therapy Phases: Overview
402
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
402
01:19Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764